Venture Funding Continues Upward Climb, But On The Backs Of Fewer Investors – BIO Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncology companies have been garnering the most investment from venture capital firms over the last 10 years due to their high levels of innovation, according to a new report from the industry group.